GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $14.97 $17.43 Friday, 19th Apr 2024 CPRX stock ended at $15.13. This is 1.37% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 5.12% from a day low at $15.03 to a day high of $15.80.
90 days $13.12 $17.50
52 weeks $11.09 $17.77

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
2021-03-22 $4.57 $5.05 $4.54 $4.69 4 530 420
2021-03-19 $4.19 $4.39 $4.15 $4.37 4 549 229
2021-03-18 $4.24 $4.39 $4.18 $4.21 1 574 875
2021-03-17 $4.07 $4.23 $4.03 $4.23 1 219 885
2021-03-16 $3.98 $4.29 $3.94 $4.15 2 346 627
2021-03-15 $3.99 $4.00 $3.85 $3.94 1 446 673
2021-03-12 $3.74 $3.90 $3.72 $3.89 1 229 407
2021-03-11 $3.76 $3.79 $3.65 $3.77 1 206 928
2021-03-10 $3.77 $3.80 $3.65 $3.72 1 149 066
2021-03-09 $3.59 $3.70 $3.57 $3.70 1 304 740
2021-03-08 $3.57 $3.69 $3.49 $3.52 1 495 155
2021-03-05 $3.56 $3.56 $3.27 $3.53 1 698 931
2021-03-04 $3.67 $3.72 $3.44 $3.50 1 914 014
2021-03-03 $3.94 $3.96 $3.67 $3.68 1 745 935
2021-03-02 $4.02 $4.05 $3.91 $3.96 1 543 167
2021-03-01 $4.00 $4.02 $3.91 $4.00 793 255
2021-02-26 $3.93 $4.04 $3.83 $3.89 1 241 784
2021-02-25 $4.06 $4.18 $3.88 $3.90 1 506 200
2021-02-24 $4.05 $4.10 $4.00 $4.03 993 325
2021-02-23 $4.16 $4.20 $3.94 $4.02 2 125 342
2021-02-22 $4.32 $4.40 $4.22 $4.28 1 187 861
2021-02-19 $4.39 $4.50 $4.34 $4.34 1 135 385
2021-02-18 $4.22 $4.45 $4.22 $4.31 1 574 493
2021-02-17 $4.17 $4.32 $4.05 $4.28 1 807 473
2021-02-16 $4.20 $4.27 $4.12 $4.12 1 558 777
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT